In addition, it has been reported that upregulated LAMP2A-mediated hyperactivation of CMA in human grade IV glioblastoma regulates malignant progression of tumor cells by targeting SMAD3 degradation (Liu et al. 2022). Here, SMAD3 is linked to neoplasm.